Pharmacology of hepzidine maleate: 4-[10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)oxy]-1-methylpiperidine hydrogen maleate (BS 7051).
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D000928:Antidepressive Agents / Q000494:pharmacology* / Q000633:toxicity; D000932:Antiemetics / Q000494:pharmacology; D001285:Atropine / Q000494:pharmacology; D001522:Behavior, Animal / Q000187:drug effects; D001717:Birds; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D005769:Gastrointestinal Motility / Q000187:drug effects; D006168:Guinea Pigs; D051379:Mice; D010276:Parasympatholytics / Q000494:pharmacology; D010640:Phenothiazines / Q000494:pharmacology; D010880:Piperidines / Q000494:pharmacology* / Q000633:toxicity; D011817:Rabbits; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012702:Serotonin Antagonists
D000928:Antidepressive Agents; D000932:Antiemetics; D010276:Parasympatholytics; D010640:Phenothiazines; D010880:Piperidines; D012702:Serotonin Antagonists; D001285:Atropine; D012110:Reserpine; D000661:Amphetamine